Original Research
Published on 31 Mar 2023
A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans
in Drug Metabolism and Transport
![A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans](https://www.frontiersin.org/files/myhome article library/1116073/1116073_Thumb_400.jpg)
- 2,406 views
- 2 citations
Original Research
Published on 31 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 24 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 22 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 21 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 15 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 14 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 13 Mar 2023
in Drug Metabolism and Transport
Clinical Trial
Published on 13 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 10 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 09 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 09 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 07 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 06 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 03 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 02 Mar 2023
in Drug Metabolism and Transport
Original Research
Published on 01 Mar 2023
in Drug Metabolism and Transport